Crestline Management, L.P. 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Crestline Management, L.P. disclosed 3 US equity positions worth $46.3m in its Q1 2026 13F filing. The largest position was DNLI at 91.7% of the reported book, followed by SANA and EGHT.
What did Crestline Management, L.P. own in Q1 2026? Top 3 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | DNLI DENALI THERAPEUTICS INC | Healthcare | 91.7% | $42.4m | 2,210,732 | – | |
| 2 | SANA SANA BIOTECHNOLOGY INC | Healthcare | 4.7% | $2.2m | 755,736 | – | |
| 3 | EGHT 8X8 INC NEW | Technology | 3.6% | $1.6m | 990,850 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.